Atlas Trials

5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis

Clinical trial NCT04552327 · COMPLETED

Trial details

NCT number
NCT04552327
Sponsor
Infectopharm Arzneimittel GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Actinic Keratosis
Start date
2020-10-14
Primary completion
2023-01-24
Enrollment
631

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.